Record Information |
---|
Version | 2.0 |
---|
Created at | 2020-11-23 19:40:48 UTC |
---|
Updated at | 2021-08-12 19:52:11 UTC |
---|
NP-MRD ID | NP0002801 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | (-)-Cotinine |
---|
Provided By | BMRB |
---|
Description | (-)-Cotinine is also known as cotinina (-)-cotinine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. (-)-Cotinine is found in Haloxylon persicum and Nicotiana tabacum. (-)-Cotinine was first documented in 2003 (PMID: 14700346). Based on a literature review a small amount of articles have been published on (-)-cotinine (PMID: 21655912) (PMID: 21953524) (PMID: 22027507). |
---|
Structure | CN1[C@@H](CCC1=O)C1=CN=CC=C1 InChI=1S/C10H12N2O/c1-12-9(4-5-10(12)13)8-3-2-6-11-7-8/h2-3,6-7,9H,4-5H2,1H3/t9-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(S)-(-)-Cotinine | ChEBI | (S)-1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone | ChEBI | (S)-Cotinine | ChEBI | Cotinina | ChEBI | Cotinine | ChEBI | Cotininum | ChEBI | Scotine | MeSH |
|
---|
Chemical Formula | C10H12N2O |
---|
Average Mass | 176.2190 Da |
---|
Monoisotopic Mass | 176.09496 Da |
---|
IUPAC Name | (5S)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-one |
---|
Traditional Name | cotinine |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN1[C@@H](CCC1=O)C1=CN=CC=C1 |
---|
InChI Identifier | InChI=1S/C10H12N2O/c1-12-9(4-5-10(12)13)8-3-2-6-11-7-8/h2-3,6-7,9H,4-5H2,1H3/t9-/m0/s1 |
---|
InChI Key | UIKROCXWUNQSPJ-VIFPVBQESA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as pyrrolidinylpyridines. These are compounds containing a pyrrolidinylpyridine ring system, which consists of a pyrrolidine ring linked to a pyridine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Pyrrolidinylpyridines |
---|
Direct Parent | Pyrrolidinylpyridines |
---|
Alternative Parents | |
---|
Substituents | - Pyrrolidinylpyridine
- Alkaloid or derivatives
- Pyrrolidone
- 2-pyrrolidone
- N-alkylpyrrolidine
- Pyrrolidine
- Tertiary carboxylic acid amide
- Heteroaromatic compound
- Lactam
- Carboxamide group
- Carboxylic acid derivative
- Azacycle
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Behera D, Uppal R, Majumdar S: Urinary levels of nicotine & cotinine in tobacco users. Indian J Med Res. 2003 Sep;118:129-33. [PubMed:14700346 ]
- Jin M, Earla R, Shah A, Earla RL, Gupte R, Mitra AK, Kumar A, Kumar S: A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers. J Neuroimmune Pharmacol. 2012 Mar;7(1):289-99. doi: 10.1007/s11481-011-9283-6. Epub 2011 Jun 8. [PubMed:21655912 ]
- Leenders M, Chuang SC, Dahm CC, Overvad K, Ueland PM, Midttun O, Vollset SE, Tjonneland A, Halkjaer J, Jenab M, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Canzian F, Boeing H, Weikert C, Trichopoulou A, Bamia C, Naska A, Palli D, Pala V, Mattiello A, Tumino R, Sacerdote C, van Duijnhoven FJ, Peeters PH, van Gils CH, Lund E, Rodriguez L, Duell EJ, Perez MJ, Molina-Montes E, Castano JM, Barricarte A, Larranaga N, Johansen D, Lindkvist B, Sund M, Ye W, Khaw KT, Wareham NJ, Michaud DS, Riboli E, Xun WW, Allen NE, Crowe FL, Bueno-de-Mesquita HB, Vineis P: Plasma cotinine levels and pancreatic cancer in the EPIC cohort study. Int J Cancer. 2012 Aug 15;131(4):997-1002. doi: 10.1002/ijc.26452. Epub 2011 Nov 2. [PubMed:21953524 ]
- Tzatzarakis MN, Vardavas CI, Terzi I, Kavalakis M, Kokkinakis M, Liesivuori J, Tsatsakis AM: Hair nicotine/cotinine concentrations as a method of monitoring exposure to tobacco smoke among infants and adults. Hum Exp Toxicol. 2012 Mar;31(3):258-65. doi: 10.1177/0960327111422401. Epub 2011 Oct 25. [PubMed:22027507 ]
|
---|